While DNA hypomethylation is reversible and required to maintain the leukemogenic potential of DNMT3A-mutant AML cells [3], the loss of Dnmt3a alone is not sufficient for leukemic transformation of normal hematopoietic stem and progenitor cells in mice [4]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.